Results 201 to 210 of about 349,749 (268)

Sustainability and Performance Evaluation in Third Sector Partnerships: The Case of Turin Fast Track City

Financial Accountability &Management, Volume 41, Issue 2, Page 381-397, May 2025.
ABSTRACT COVID‐19 radically changed how public services (activities of general interest) are pursued and administered. The search for resilient models has prompted public administration to test new regulatory approaches and to involve the third sector in the provision of primary services. This study investigates the sustainability and capacity of these
Stefano Amelio, Patrizia Gazzola, Paolo Biancone, Valerio Brescia   +3 more
wiley   +1 more source

Heplisav-B vs Standard Hepatitis B Vaccine Booster for Health Care Workers. [PDF]

Ann Fam Med
Williams AL, Newman RS.
europepmc   +1 more source

Hepatitis B Vaccine Is Not Associated with Liver Problems in U.S. Children Less Than 6 Years Old

, 2000
Pierre Van Damme, Koen Van Herck, A. Meheus   +2 more
openalex   +2 more sources

Emergence of vaccine-induced escape mutant of hepatitis b virus with multiple surface gene mutations in a korean child [PDF]

, 2001
Kee Myung Lee, Young Soo Kim, Young Yoon Ko, Byung Moo Yoo, Kwang Jae Lee, Jin Hong Kim, Ki Baik Hahm, Sung Won Cho   +7 more
openalex   +1 more source

Cost‐Effectiveness of Universal Screen‐and‐Treat Strategies for Reducing Morbidity and Mortality of Chronic Hepatitis B in a High‐Endemicity City

Journal of Viral Hepatitis, Volume 32, Issue 5, May 2025.
ABSTRACT In the setting of high hepatitis B virus (HBV) endemicity, we studied the cost‐effectiveness of universal HBV screen‐and‐treat strategies for averting HBV‐related morbidity and mortality in Hong Kong, where diagnosis and treatment coverages are low.
Ngai Sze Wong, Denise Pui‐Chung Chan, Grace Lai‐Hung Wong, Shui Shan Lee   +3 more
wiley   +1 more source

Reactivity pattern of a human monoclonal antibody against recombinant hepatitis B vaccine to hbsag immune escape mutants

, 2000
Michel P. Cooreman, C. M. G. Sünnen, Lieven Verhoye, Mark H. Van Roosmalen, Wilma P. Paulij, Geert Leroux‐Roels   +5 more
openalex   +1 more source

Hepatitis B vaccine in infants: a randomized controlled trial comparing gluteal versus anterolateral thigh muscle administration [PDF]

, 2001
Andrea Santos Rafael ALVES, Cristiane Murta‐Nascimento, Celso H. GRANATO, Helena Keiko Sato, Marina F. MORGATO, Cláudio Mendes Pannuti   +5 more
openalex   +1 more source

Universal Prophylactic Antitumor Vaccination Using Stem Cell Membrane‐Coated Nanoparticles

Advanced Materials, Volume 37, Issue 14, April 9, 2025.
Induced pluripotent stem cell membrane is coated onto adjuvant‐loaded nanoparticle cores to create a universal cancer vaccine. The formulation utilizes oncofetal antigens present on the cell membrane to elicit broadly protective immune responses in vivo.
Nishta Krishnan, Jiarong Zhou, Animesh Mohapatra, Christian John Ventura, Yaou Duan, Junyong Lee, Jacob J. Hoenig, Oliver Nizet, Weiwei Gao, Ronnie H. Fang, Liangfang Zhang   +10 more
wiley   +1 more source

Hepatitis B immunisation of household contacts: retrospective study of vaccine coverage [PDF]

, 2001
Gabriele Richardson
openalex   +1 more source

Achieving Optimal Health With Host‐Directed Therapies (HDTs) in Infectious Diseases—A New Horizon

Advanced Therapeutics, Volume 8, Issue 4, April 2025.
Host‐directed therapies (HDTs) represent a transformative approach in infectious disease management by targeting host factors to enhance immune responses and inhibit viral replication. This innovative strategy leverages advanced genomics and gene editing technologies, offering promising avenues for improved patient outcomes and a new horizon in ...
Amol D. Gholap, Pankaj R. Khuspe, Sagar R. Pardeshi, Md Jasim Uddin, Ushasi Das, Navnath T. Hatvate, Satish Rojekar, Prabhanjan Giram, Mohammad Khalid, Yahya E. Choonara, Md. Faiyazuddin   +10 more
wiley   +1 more source